Goldman Sachs’s Madrigal Pharmaceuticals MDGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$57.5M Buy
189,840
+201
+0.1% +$60.8K 0.01% 1059
2025
Q1
$62.8M Sell
189,639
-41,811
-18% -$13.8M 0.01% 925
2024
Q4
$71.4M Sell
231,450
-8,330
-3% -$2.57M 0.01% 854
2024
Q3
$50.9M Buy
239,780
+68,329
+40% +$14.5M 0.01% 1046
2024
Q2
$48M Buy
171,451
+79,662
+87% +$22.3M 0.01% 1015
2024
Q1
$24.5M Buy
91,789
+6,686
+8% +$1.79M ﹤0.01% 1404
2023
Q4
$19.7M Buy
85,103
+8,691
+11% +$2.01M ﹤0.01% 1567
2023
Q3
$11.2M Buy
76,412
+6,103
+9% +$891K ﹤0.01% 1908
2023
Q2
$16.2M Sell
70,309
-72,682
-51% -$16.8M ﹤0.01% 1703
2023
Q1
$34.6M Sell
142,991
-20,800
-13% -$5.04M 0.01% 1137
2022
Q4
$47.5M Sell
163,791
-16,611
-9% -$4.82M 0.01% 1007
2022
Q3
$11.7M Buy
180,402
+127,776
+243% +$8.3M ﹤0.01% 2009
2022
Q2
$3.77M Buy
52,626
+4,038
+8% +$289K ﹤0.01% 2920
2022
Q1
$4.77M Sell
48,588
-56,891
-54% -$5.58M ﹤0.01% 2840
2021
Q4
$8.94M Sell
105,479
-49,691
-32% -$4.21M ﹤0.01% 2364
2021
Q3
$12.4M Buy
155,170
+45,883
+42% +$3.66M ﹤0.01% 2092
2021
Q2
$10.6M Buy
109,287
+20,441
+23% +$1.99M ﹤0.01% 2203
2021
Q1
$10.4M Buy
88,846
+20,738
+30% +$2.43M ﹤0.01% 2176
2020
Q4
$7.57M Sell
68,108
-46,794
-41% -$5.2M ﹤0.01% 2221
2020
Q3
$13.6M Buy
114,902
+10,305
+10% +$1.22M ﹤0.01% 1744
2020
Q2
$11.8M Sell
104,597
-97,270
-48% -$11M ﹤0.01% 1845
2020
Q1
$13.5M Buy
201,867
+37,066
+22% +$2.47M ﹤0.01% 1594
2019
Q4
$15M Buy
164,801
+60,567
+58% +$5.52M ﹤0.01% 1791
2019
Q3
$8.99M Sell
104,234
-937
-0.9% -$80.8K ﹤0.01% 1988
2019
Q2
$11M Sell
105,171
-16,917
-14% -$1.77M ﹤0.01% 1905
2019
Q1
$15.3M Buy
122,088
+34,378
+39% +$4.31M ﹤0.01% 1776
2018
Q4
$9.89M Buy
87,710
+16,845
+24% +$1.9M ﹤0.01% 1931
2018
Q3
$15.2M Buy
70,865
+31,623
+81% +$6.77M ﹤0.01% 1807
2018
Q2
$11M Buy
39,242
+36,536
+1,350% +$10.2M ﹤0.01% 1961
2018
Q1
$316K Sell
2,706
-2,287
-46% -$267K ﹤0.01% 3683
2017
Q4
$458K Buy
+4,993
New +$458K ﹤0.01% 3490
2017
Q2
Sell
-20,836
Closed -$321K 4465
2017
Q1
$321K Buy
+20,836
New +$321K ﹤0.01% 3745
2016
Q4
Sell
-12,043
Closed -$153K 4510
2016
Q3
$153K Buy
12,043
+4,472
+59% +$56.8K ﹤0.01% 4038
2016
Q2
$69K Buy
7,571
+4,326
+133% +$39.4K ﹤0.01% 4209
2016
Q1
$27K Sell
3,245
-34,034
-91% -$283K ﹤0.01% 4333
2015
Q4
$459K Buy
37,279
+23,083
+163% +$284K ﹤0.01% 3298
2015
Q3
$865K Buy
14,196
+4,946
+53% +$301K ﹤0.01% 2988
2015
Q2
$722K Sell
9,250
-1,861
-17% -$145K ﹤0.01% 3126
2015
Q1
$754K Sell
11,111
-415
-4% -$28.2K ﹤0.01% 3077
2014
Q4
$1.07M Sell
11,526
-11,052
-49% -$1.03M ﹤0.01% 2885
2014
Q3
$2.38M Buy
22,578
+837
+4% +$88.2K ﹤0.01% 2414
2014
Q2
$3.11M Buy
21,741
+846
+4% +$121K ﹤0.01% 2289
2014
Q1
$3.15M Buy
20,895
+16,902
+423% +$2.55M ﹤0.01% 2295
2013
Q4
$732K Buy
3,993
+3,102
+348% +$569K ﹤0.01% 3228
2013
Q3
$197K Sell
891
-9,206
-91% -$2.04M ﹤0.01% 3842
2013
Q2
$1.76M Buy
+10,097
New +$1.76M ﹤0.01% 2454